July 2022
Fyarro and Tivdak will have requirements for URMBT members with Blue Cross non-Medicare plans
For dates of service on or after Aug. 16, 2022, the drugs listed below will require prior authorization through AIM Specialty Health® and may also have site-of-care requirements, quantity limit requirements or both. These requirements will apply to UAW Retiree Medical Benefits Trust members with Blue Cross non-Medicare plans. These drugs are part of members’ medical benefits, not their pharmacy benefits.
See the table for more information. When a cell is blank, the drug doesn’t have that requirement.
Brand name |
Generic name |
HCPCS code |
Requirements |
Prior authorization |
Site of care |
Quantity limits |
Fyarro™ |
sirolimus protein-bound particles |
J9331 |
✓ |
|
|
Tivdak® |
tisotumab vedotin-tftv |
J9273 |
✓ |
|
|
These requirements apply only when these drugs are administered in an outpatient setting.
Note: These requirements don’t apply to the UAW Retiree Health Care Trust (group number 70605) or the UAW International Union (group number 71714).
How to submit authorization requests
Submit prior authorization requests to AIM using one of the following methods:
More about the authorization requirements Authorization isn’t a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for members.
For additional information on requirements related to drugs covered under the medical benefit for URMBT members with Blue Cross non-Medicare plans, see:
We’ll update the pertinent drug lists to reflect the information in this article prior to the effective date.
Note: Accredo manages prior authorization requests for additional medical benefit drugs for these members.
AIM Specialty Health is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to manage authorizations for select services. For more information, go to our ereferrals.bcbsm.com website.
**Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website. |